nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—HSD3B2—zona glomerulosa of adrenal gland—adrenal gland cancer	0.409	0.673	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—adrenal cortex—adrenal gland cancer	0.0199	0.0327	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—gonad—adrenal gland cancer	0.0165	0.0271	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—pituitary gland—adrenal gland cancer	0.0161	0.0264	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—adrenal gland—adrenal gland cancer	0.0144	0.0236	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—urine—adrenal gland cancer	0.0124	0.0204	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—urine—adrenal gland cancer	0.0123	0.0202	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—urine—adrenal gland cancer	0.00936	0.0154	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—adrenal cortex—adrenal gland cancer	0.00839	0.0138	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cardiac atrium—adrenal gland cancer	0.00694	0.0114	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—pituitary gland—adrenal gland cancer	0.00678	0.0112	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—adrenal gland—adrenal gland cancer	0.00606	0.00996	CbGeAlD
Medroxyprogesterone Acetate—SHBG—gonad—adrenal gland cancer	0.00522	0.00859	CbGeAlD
Medroxyprogesterone Acetate—SHBG—pituitary gland—adrenal gland cancer	0.0051	0.00838	CbGeAlD
Medroxyprogesterone Acetate—PGR—pituitary gland—adrenal gland cancer	0.00459	0.00755	CbGeAlD
Medroxyprogesterone Acetate—SHBG—adrenal gland—adrenal gland cancer	0.00455	0.00749	CbGeAlD
Medroxyprogesterone Acetate—AR—adrenal cortex—adrenal gland cancer	0.00453	0.00745	CbGeAlD
Medroxyprogesterone Acetate—PGR—adrenal gland—adrenal gland cancer	0.0041	0.00675	CbGeAlD
Medroxyprogesterone Acetate—AR—gonad—adrenal gland cancer	0.00375	0.00617	CbGeAlD
Medroxyprogesterone Acetate—AR—cardiac atrium—adrenal gland cancer	0.00374	0.00616	CbGeAlD
Medroxyprogesterone Acetate—ESR1—gonad—adrenal gland cancer	0.00368	0.00605	CbGeAlD
Medroxyprogesterone Acetate—AR—pituitary gland—adrenal gland cancer	0.00366	0.00602	CbGeAlD
Medroxyprogesterone Acetate—ESR1—pituitary gland—adrenal gland cancer	0.00359	0.00591	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—adrenal cortex—adrenal gland cancer	0.00328	0.00539	CbGeAlD
Medroxyprogesterone Acetate—AR—adrenal gland—adrenal gland cancer	0.00327	0.00538	CbGeAlD
Medroxyprogesterone Acetate—ESR1—adrenal gland—adrenal gland cancer	0.00321	0.00528	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—pituitary gland—adrenal gland cancer	0.00296	0.00487	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0029	0.00757	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—gonad—adrenal gland cancer	0.00272	0.00447	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cardiac atrium—adrenal gland cancer	0.00271	0.00446	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.0027	0.00705	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—pituitary gland—adrenal gland cancer	0.00265	0.00436	CbGeAlD
Medroxyprogesterone Acetate—ESR1—Estrogen signaling pathway—BRAF—adrenal gland cancer	0.00259	0.00676	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00242	0.00633	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.00239	0.00624	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—adrenal gland—adrenal gland cancer	0.00237	0.00389	CbGeAlD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00227	0.00592	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00221	0.00577	CbGpPWpGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—adrenal gland cancer	0.00217	0.229	CrCbGaD
Medroxyprogesterone Acetate—Megestrol acetate—ABCB1—adrenal gland cancer	0.00211	0.223	CrCbGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00211	0.0055	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SDHB—adrenal gland cancer	0.00205	0.00535	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Notch-mediated HES/HEY network—RB1—adrenal gland cancer	0.00186	0.00487	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—CDC42—adrenal gland cancer	0.00179	0.00468	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00175	0.00456	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—PRKACA—adrenal gland cancer	0.00171	0.00447	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.0017	0.00445	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00162	0.00424	CbGpPWpGaD
Medroxyprogesterone Acetate—Methylprednisolone—ABCB1—adrenal gland cancer	0.00162	0.171	CrCbGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00161	0.00421	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00158	0.00414	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—CDC42—adrenal gland cancer	0.00158	0.00413	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—RB1—adrenal gland cancer	0.00157	0.0041	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.00156	0.00409	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—adrenal gland cancer	0.00149	0.0039	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00146	0.00381	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00145	0.00378	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—CDKN2A—adrenal gland cancer	0.00138	0.00361	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00138	0.00361	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—TERT—adrenal gland cancer	0.00137	0.00358	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00135	0.00352	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—adrenal gland cancer	0.00133	0.00347	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—RRM1—adrenal gland cancer	0.00132	0.00345	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SDHD—adrenal gland cancer	0.00132	0.00345	CbGpPWpGaD
Medroxyprogesterone Acetate—Spironolactone—ABCB1—adrenal gland cancer	0.00131	0.139	CrCbGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.0013	0.0034	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.0013	0.00339	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.0012	0.00313	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.0012	0.00313	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.00117	0.00306	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.00112	0.00292	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—CTNNB1—adrenal gland cancer	0.00111	0.00291	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—BAD—adrenal gland cancer	0.0011	0.00288	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00109	0.00285	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.00107	0.0028	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—BAD—adrenal gland cancer	0.00107	0.00279	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SH3KBP1—adrenal gland cancer	0.00103	0.00268	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00102	0.00268	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00102	0.00267	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SDHB—adrenal gland cancer	0.00101	0.00264	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.001	0.00262	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.001	0.00261	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.000985	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—MED12—adrenal gland cancer	0.000984	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000978	0.00256	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ZNRF3—adrenal gland cancer	0.000965	0.00252	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000955	0.0025	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.000933	0.00244	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000917	0.0024	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000911	0.00238	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00091	0.00238	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000903	0.00236	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000903	0.00236	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000895	0.00234	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000888	0.00232	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000879	0.0023	CbGpPWpGaD
Medroxyprogesterone Acetate—Hydrocortisone—ABCB1—adrenal gland cancer	0.000871	0.0921	CrCbGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00085	0.00222	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.000822	0.00215	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR5A1—adrenal gland cancer	0.00082	0.00214	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000818	0.00214	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000796	0.00208	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00078	0.00204	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GNRHR—adrenal gland cancer	0.000773	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Endoderm Differentiation—CTNNB1—adrenal gland cancer	0.000773	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000767	0.002	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000756	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—adrenal gland cancer	0.000754	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000745	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000745	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000738	0.00193	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000732	0.00191	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000719	0.00188	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PRKACA—adrenal gland cancer	0.000718	0.00188	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—ABCB1—adrenal gland cancer	0.00071	0.0751	CrCbGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000702	0.00183	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000701	0.00183	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000682	0.00178	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000678	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000676	0.00177	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone—ABCB1—adrenal gland cancer	0.000671	0.071	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—RRM1—adrenal gland cancer	0.000652	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SDHD—adrenal gland cancer	0.000652	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.000651	0.0017	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00063	0.00165	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—BAD—adrenal gland cancer	0.000627	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—RB1—adrenal gland cancer	0.000626	0.00164	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR5A1—adrenal gland cancer	0.000625	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—EGFR—adrenal gland cancer	0.000622	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GNRHR—adrenal gland cancer	0.00061	0.00159	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—SPRY2—adrenal gland cancer	0.000605	0.00158	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000601	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MED12—adrenal gland cancer	0.000601	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000599	0.00156	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MED12—adrenal gland cancer	0.000592	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GNAS—adrenal gland cancer	0.000582	0.00152	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000574	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000574	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ABCB1—adrenal gland cancer	0.000571	0.00149	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000567	0.00148	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000566	0.00148	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000564	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000557	0.00146	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000555	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MEN1—adrenal gland cancer	0.000554	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000538	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000533	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000525	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000522	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—adrenal gland cancer	0.00051	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—adrenal gland cancer	0.000503	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000499	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MED12—adrenal gland cancer	0.000493	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000487	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MED12—adrenal gland cancer	0.000486	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR5A1—adrenal gland cancer	0.000481	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NR5A1—adrenal gland cancer	0.000474	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MEN1—adrenal gland cancer	0.000471	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GNRH1—adrenal gland cancer	0.000463	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—CTNNB1—adrenal gland cancer	0.00046	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000446	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.000443	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000434	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000427	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000424	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PRKACA—adrenal gland cancer	0.000423	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000415	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSHR—adrenal gland cancer	0.000413	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000398	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000396	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—POMC—adrenal gland cancer	0.000392	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MEN1—adrenal gland cancer	0.000388	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000384	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MED12—adrenal gland cancer	0.000376	0.000981	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GNRH1—adrenal gland cancer	0.000365	0.000955	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDC42—adrenal gland cancer	0.000359	0.000938	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MEN1—adrenal gland cancer	0.000359	0.000938	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000358	0.000936	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000358	0.000936	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PRKACA—adrenal gland cancer	0.000354	0.000926	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000353	0.000924	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000346	0.000905	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000344	0.000898	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SPRY2—adrenal gland cancer	0.000334	0.000874	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000333	0.00087	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000329	0.000859	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—adrenal gland cancer	0.000327	0.000854	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSHR—adrenal gland cancer	0.000326	0.000851	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000321	0.00084	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000318	0.000831	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000313	0.000818	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—adrenal gland cancer	0.000312	0.000816	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000307	0.000802	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MEN1—adrenal gland cancer	0.000306	0.0008	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000297	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000296	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MED12—adrenal gland cancer	0.000289	0.000756	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TERT—adrenal gland cancer	0.000288	0.000753	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GNAS—adrenal gland cancer	0.000287	0.000751	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MED12—adrenal gland cancer	0.000285	0.000745	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.000284	0.000743	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ABCB1—adrenal gland cancer	0.000282	0.000737	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MEN1—adrenal gland cancer	0.000276	0.000722	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000276	0.000721	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MEN1—adrenal gland cancer	0.000272	0.000712	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000272	0.000712	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000259	0.000676	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDC42—adrenal gland cancer	0.000251	0.000657	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BAD—adrenal gland cancer	0.000251	0.000655	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00025	0.000652	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF2—adrenal gland cancer	0.000242	0.000633	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GNAS—adrenal gland cancer	0.00024	0.000628	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000234	0.000612	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRKACA—adrenal gland cancer	0.000234	0.000611	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000231	0.000605	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000229	0.000597	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BRAF—adrenal gland cancer	0.000228	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000224	0.000585	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000215	0.000561	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TERT—adrenal gland cancer	0.000202	0.000527	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDC42—adrenal gland cancer	0.000198	0.000518	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000196	0.000513	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—POMC—adrenal gland cancer	0.000193	0.000505	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSHR—adrenal gland cancer	0.000191	0.0005	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF2—adrenal gland cancer	0.000191	0.0005	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GNAS—adrenal gland cancer	0.000189	0.000495	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1R—adrenal gland cancer	0.000185	0.000483	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—adrenal gland cancer	0.000184	0.000481	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RRM1—adrenal gland cancer	0.000183	0.000479	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SDHD—adrenal gland cancer	0.000183	0.000479	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000182	0.000476	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00018	0.00047	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BAD—adrenal gland cancer	0.000175	0.000458	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000171	0.000446	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CTNNB1—adrenal gland cancer	0.000165	0.000431	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—POMC—adrenal gland cancer	0.000162	0.000423	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BRAF—adrenal gland cancer	0.00016	0.000417	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TERT—adrenal gland cancer	0.000159	0.000416	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—adrenal gland cancer	0.000154	0.000403	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000153	0.000399	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000149	0.00039	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000149	0.00039	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BAD—adrenal gland cancer	0.000138	0.000362	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000137	0.000359	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MED12—adrenal gland cancer	0.000137	0.000357	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—adrenal gland cancer	0.000131	0.000341	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—POMC—adrenal gland cancer	0.000128	0.000333	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BRAF—adrenal gland cancer	0.000126	0.000329	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000122	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDC42—adrenal gland cancer	0.000116	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000115	0.000302	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF2—adrenal gland cancer	0.000112	0.000293	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNAS—adrenal gland cancer	0.000111	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000111	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000108	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	9.97e-05	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.94e-05	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SDHD—adrenal gland cancer	9.83e-05	0.000257	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RRM1—adrenal gland cancer	9.83e-05	0.000257	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.74e-05	0.000255	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TERT—adrenal gland cancer	9.34e-05	0.000244	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—adrenal gland cancer	9.15e-05	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CTNNB1—adrenal gland cancer	9.11e-05	0.000238	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BAD—adrenal gland cancer	8.12e-05	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	8.11e-05	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GNAS—adrenal gland cancer	8.08e-05	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.93e-05	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	7.93e-05	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—adrenal gland cancer	7.68e-05	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—POMC—adrenal gland cancer	7.49e-05	0.000196	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BRAF—adrenal gland cancer	7.39e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.33e-05	0.000192	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—adrenal gland cancer	7.21e-05	0.000189	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GNAS—adrenal gland cancer	6.57e-05	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	6.45e-05	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—adrenal gland cancer	6.06e-05	0.000158	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—POMC—adrenal gland cancer	5.44e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.35e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.34e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—POMC—adrenal gland cancer	4.43e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	4.34e-05	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.34e-05	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.25e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—adrenal gland cancer	4.23e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—adrenal gland cancer	3.55e-05	9.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	3.53e-05	9.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.92e-05	7.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.33e-05	6.08e-05	CbGpPWpGaD
